Skip to main content
. 2004 Jul 29;6(5):R556–R570. doi: 10.1186/bcr898

Figure 3.

Figure 3

Immunocytochemistry targeting cytokeratins (CKs) in bone marrow (BM) aspirates from breast cancer patients. (a) Distribution of CK-positive cells for 32 patients. (b) CK-positive cells labeled (purple) by immunocytochemistry performed on BM mononuclear cell cytospots of one breast cancer patient with 'advanced disease' (PM634).